These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3057000)

  • 41. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
    Jenkins RE; Rodenas J; Bhogal BS; Black MM
    Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermolysis bullosa acquisita in a Great Dane.
    Hill PB; Boyer P; Lau P; Rybnicek J; Hargreaves J; Olivry T
    J Small Anim Pract; 2008 Feb; 49(2):89-94. PubMed ID: 17784932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Adquired epidermolysis bullosa. Immunopathological and ultrastructural studies].
    Mascaró JM; Jorda E; Calap J; Botella R; Febrer I
    Med Cutan Ibero Lat Am; 1978; 6(1):1-7. PubMed ID: 384109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
    Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
    Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
    Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
    J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
    Chan LS; Cooper KD
    Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
    Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
    Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epidermolysis bullosa acquisita--manifestations in otorhinolaryngology].
    Schenk P; Konrad K
    Laryngol Rhinol Otol (Stuttg); 1983 Oct; 62(10):456-62. PubMed ID: 6358736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ocular involvement in epidermolysis bullosa acquisita.
    Zierhut M; Thiel HJ; Weidle EG; Steuhl KP; Sönnichsen K; Schaumburg-Lever G
    Arch Ophthalmol; 1989 Mar; 107(3):398-401. PubMed ID: 2647069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases.
    García-Díez I; Martínez-Escala ME; Ishii N; Hashimoto T; Mascaró Galy JM; Pujol RM; Herrero-González JE
    Actas Dermosifiliogr; 2017; 108(1):e1-e5. PubMed ID: 27095685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients.
    Nieboer C; Boorsma DM; Woerdeman MJ; Kalsbeek GL
    Br J Dermatol; 1980 Apr; 102(4):383-92. PubMed ID: 6992836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita.
    Kofler H; Wambacher-Gasser B; Topar G; Weinlich G; Schuler G; Hintner H; Romani N; Fritsch P
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 2):331-5. PubMed ID: 9039213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclosporine controls epidermolysis bullosa acquisita co-occurring with acquired factor VIII deficiency.
    Maize JC; Cohen JB
    Int J Dermatol; 2005 Aug; 44(8):692-4. PubMed ID: 16101876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunopathology of epidermolysis bullosa acquisita. Association with mixed cryoglobulinemia.
    Krivo JM; Miller F
    Arch Dermatol; 1978 Aug; 114(8):1218-20. PubMed ID: 354536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidermolysis bullosa acquisita antigen is synthesized by human keratinocytes cultured in serum-free medium.
    Woodley DT; Briggaman RA; Gammon WR; O'Keefe EJ
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1267-72. PubMed ID: 2411267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidermolysis bullosa acquisita in an 8-year-old girl.
    Borok M; Heng MC; Ahmed AR
    Pediatr Dermatol; 1986 Sep; 3(4):315-22. PubMed ID: 3774650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin.
    Campos M; Silvente C; Lecona M; Suárez R; Lázaro P
    Clin Exp Dermatol; 2006 Jan; 31(1):71-3. PubMed ID: 16309488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid.
    Mooney E; Falk RJ; Gammon WR
    Arch Dermatol; 1992 Jan; 128(1):58-60. PubMed ID: 1371212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.